Brett M. Antonio

795 total citations
14 papers, 461 citations indexed

About

Brett M. Antonio is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Brett M. Antonio has authored 14 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Brett M. Antonio's work include Ion channel regulation and function (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Brett M. Antonio is often cited by papers focused on Ion channel regulation and function (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Brett M. Antonio collaborates with scholars based in United States, United Kingdom and Australia. Brett M. Antonio's co-authors include Neil A. Castle, David Printzenhoff, Zhixin Lin, Aaron C. Gerlach, Karen Padilla, Brian E. Marron, Mark L. Chapman, Douglas S. Krafte, Nigel A. Swain and Christopher W. West and has published in prestigious journals such as Proceedings of the National Academy of Sciences, British Journal of Pharmacology and Pharmaceutical Research.

In The Last Decade

Brett M. Antonio

14 papers receiving 447 citations

Peers

Countries citing papers authored by Brett M. Antonio

Since Specialization

Citations

This map shows the geographic impact of Brett M. Antonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett M. Antonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett M. Antonio more than expected).

Fields of papers citing papers by Brett M. Antonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett M. Antonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett M. Antonio. The network helps show where Brett M. Antonio may publish in the future.

Co-authorship network of co-authors of Brett M. Antonio

This figure shows the co-authorship network connecting the top 25 collaborators of Brett M. Antonio. A scholar is included among the top collaborators of Brett M. Antonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett M. Antonio. Brett M. Antonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery 2024 ·mAbs ·Christine N. Vuong, Kevin A. Reynolds, (unknown), (unknown), (unknown), Manith Norng, Yulei Zhang, (unknown), Darlene Pedersen, (unknown), Ellen J. Collarini, (unknown), Shelley Izquierdo, Eric G. Vajda, Brett M. Antonio, Devendra B. Srivastava, Marie‐Cecile van de Lavoir, Yasmina Abdiche, William Harriman, Philip A. Leighton	3
2	Discovery of the First Orally Available, Selective K_Na1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series 2021 ·ACS Medicinal Chemistry Letters ·Andrew M. Griffin, Kristopher M. Kahlig, Robert J. Hatch, Zoë A. Hughes, Mark L. Chapman, Brett M. Antonio, Brian E. Marron, Marion Wittmann, Gabriel Martínez-Botella	24
3	Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome 2019 ·Pharmaceutical Research ·Sean Ekins, (unknown), Kimberley M. Zorn, Brett M. Antonio, Zhixin Lin, Aaron C. Gerlach	39
4	A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy 2018 ·Epilepsia ·Talia A. Atkin, (unknown), Aaron C. Gerlach, (unknown), Brett M. Antonio, (unknown), Karen Padilla, (unknown), Douglas S. Krafte, (unknown), Gregory R. Stewart, Slavé Petrovski, Orrin Devinsky, Matthew Might, Steven Petrou, David B. Goldstein	33
5	TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype 2018 ·Proceedings of the National Academy of Sciences ·(unknown), David C. Pryde, (unknown), Karen Padilla, Brett M. Antonio, Seungil Han, Veerabahu Shanmugasundaram, Aaron C. Gerlach	11
6	Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors 2018 ·ACS Medicinal Chemistry Letters ·M. F. Sammons, Sujay V. Kharade, Kevin J. Filipski, Markus Boehm, Aaron Smith, Andre Shavnya, Dilinie P. Fernando, Matthew Dowling, Philip A. Carpino, Neil A. Castle, (unknown), Brett M. Antonio, J Gosset, Anthony Carlo, Jerod S. Denton	3
7	Discovery of a Series of Indazole TRPA1 Antagonists 2017 ·ACS Medicinal Chemistry Letters ·David C. Pryde, Brian E. Marron, Christopher W. West, (unknown), George Amato, (unknown), Brett M. Antonio, Karen Padilla, (unknown), (unknown), Joseph S. Warmus, Nigel A. Swain, Kiyoyuki Omoto, John H. Mahoney, Aaron C. Gerlach	19
8	GI‐530159, a novel, selective, mechanosensitive two‐pore‐domain potassium (K_2P) channel opener, reduces rat dorsal root ganglion neuron excitability 2017 ·British Journal of Pharmacology ·Alexandre Loucif, Pierre‐Philippe Saintot, Jia Liu, Brett M. Antonio, (unknown), (unknown), Emma L. Veale, Anna Wilbrey, Kiyoyuki Omoto, Lishuang Cao, Alex Gutteridge, Neil A. Castle, Edward B. Stevens, Alistair Mathie	40
9	Validation of ion channel targets 2015 ·Channels ·Aaron C. Gerlach, Brett M. Antonio	7
10	Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels 2013 ·Proceedings of the National Academy of Sciences ·Ken McCormack, (unknown), Mark L. Chapman, Douglas S. Krafte, Brian E. Marron, Christopher W. West, Michael J. Krambis, Brett M. Antonio, (unknown), David Printzenhoff, Karen Padilla, Zhixin Lin, P. Kay Wagoner, Nigel A. Swain, Paul A. Stupple, Marcel de Groot, Richard P. Butt, Neil A. Castle	174
11	N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy 2011 ·ACS Medicinal Chemistry Letters ·George Amato, Rosemarie Roeloffs, Greg C. Rigdon, Brett M. Antonio, (unknown), Grant McNaughton‐Smith, Alan D. Wickenden, Paul C. Fritch, Mark J. Suto	40
12	Sodium Channel Inhibitor Drug Discovery Using Automated High Throughput Electrophysiology Platforms 2009 ·Combinatorial Chemistry & High Throughput Screening ·Neil A. Castle, David Printzenhoff, (unknown), Brett M. Antonio, Alan Wickenden, Christopher Silvia	43
13	The Effect of κ-Opioid Receptor Agonists on Tetrodotoxin-Resistant Sodium Channels in Primary Sensory Neurons 2009 ·Anesthesia & Analgesia ·Xin Su, Neil A. Castle, Brett M. Antonio, Rosemarie Roeloffs, James B. Thomas, Douglas S. Krafte, Mark L. Chapman	10
14	High-Throughput Screen for Inhibitors of 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase by Surrogate Ligand Competition 2003 ·SLAS DISCOVERY ·Elizabeth B. Gottlin, R. Edward Benson, (unknown), Brett M. Antonio, (unknown), E.S. Payne, S. M. Ashraf, Dale J. Christensen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact